Cingulate Inc. (NASDAQ:CINGW) Short Interest Up 186.7% in May

Cingulate Inc. (NASDAQ:CINGW) saw a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 10,882 shares, a growth of 186.7% from the May 14th total of 3,796 shares. Based on an average trading volume of 57,882 shares, the days-to-cover ratio is presently 0.2 days.

Cingulate Price Performance

Shares of CINGW traded down $0.00 during mid-day trading on Friday, reaching $0.03. 200 shares of the company were exchanged, compared to its average volume of 40,903. Cingulate has a 52 week low of $0.02 and a 52 week high of $0.18. The business has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.05.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.